What are the risks for companies manufacturing in China amid US controls?

Question

Accepted Answer

Teradyne Faced Significant Risks and Disruptions After Moving Manufacturing from China Due to US Export Controls

Teradyne, a key supplier of semiconductor testing equipment, incurred substantial costs and experienced supply chain disruptions when it moved approximately US$1 billion in manufacturing out of China. This decision was a direct consequence of US export regulations enacted in October 2022, which imposed restrictions on the export of technology to semiconductor manufacturing facilities within China. The regulations aimed to prevent American technological advancements from benefiting China's military capabilities.
Supply Chain Disruptions and Supplier Refusal

The implementation of US export controls created significant operational challenges for Teradyne. Even after obtaining emergency authorization to continue its manufacturing activities in Suzhou, some suppliers refused to ship necessary components to the company. This refusal, despite Teradyne's compliance efforts, led to considerable supply chain disruptions, highlighting the complex and often unpredictable nature of navigating international trade regulations.
Significant Financial and Market Share Impact

The move of manufacturing operations out of China was not without substantial expense for Teradyne. The company had previously warned investors about the potential impact of these regulations, and by October 2023, it confirmed that the restrictions affected both its sales to certain Chinese entities and its internal manufacturing and development operations. This situation has evidently impacted the company's market share, as indicated by a decrease in revenue contribution from China.
Evolving Regulations and Ongoing Compliance Challenges

While Teradyne eventually secured licenses to mitigate the impact of the initial regulations, the compliance landscape continued to evolve. The US updated its rules in October 2023, introducing an exception for testing equipment used in the post-wafer creation stages. Despite this, Teradyne's director of global compliance and ethics noted that the issue remained a high priority, emphasizing the ongoing need for vigilance and adaptation in managing operations amidst these controls.

Reading history

Hide →

This history is cleared when the page is closed.

What are the risks for companies manufacturing in China amid US controls?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends